Congo red and protein aggregation in neurodegenerative diseases
- PMID: 16959325
- DOI: 10.1016/j.brainresrev.2006.08.001
Congo red and protein aggregation in neurodegenerative diseases
Abstract
Congo red is a commonly used histological dye for amyloid detection. The specificity of this staining results from Congo red's affinity for binding to fibril proteins enriched in beta-sheet conformation. Unexpectedly, recent investigations indicate that the dye also possesses the capacity to interfere with processes of protein misfolding and aggregation, stabilizing native protein monomers or partially folded intermediates, while reducing concentration of more toxic protein oligomers. Inhibitory effects of Congo red upon amyloid toxicity may also range from blockade of channel formation and interference with glycosaminoglycans binding or immune functions, to the modulation of gene expression. Particularly, Congo red exhibits ameliorative effect in models of neurodegenerative disorders, such as Alzheimer's, Parkinson's, Huntington's and prion diseases. Another interesting application of Congo red analogues is the development of imaging probes. Based on their small molecular size and penetrability through blood-brain barrier, Congo red congeners can be used for both antemortem and in vivo visualization and quantification of brain amyloids. Therefore, understanding mechanisms involved in dye-amyloidal fibril binding and inhibition of aggregation will provide instructive guides for the design of future compounds, potentially useful for monitoring and treating neurodegenerative diseases.
Similar articles
-
Systemic administration of Congo red does not improve motor or cognitive function in R6/2 mice.Neurobiol Dis. 2007 Feb;25(2):342-53. doi: 10.1016/j.nbd.2006.09.015. Epub 2006 Nov 7. Neurobiol Dis. 2007. PMID: 17095235
-
Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.Biochemistry. 1998 Mar 17;37(11):3602-11. doi: 10.1021/bi972029u. Biochemistry. 1998. PMID: 9521679
-
Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations.J Am Chem Soc. 2007 Feb 7;129(5):1225-32. doi: 10.1021/ja0662772. J Am Chem Soc. 2007. PMID: 17263405
-
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.Neurobiol Aging. 2006 Apr;27(4):570-5. doi: 10.1016/j.neurobiolaging.2005.04.017. Epub 2006 Feb 14. Neurobiol Aging. 2006. PMID: 16481071 Review.
-
X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.Methods Enzymol. 2006;412:123-44. doi: 10.1016/S0076-6879(06)12009-1. Methods Enzymol. 2006. PMID: 17046656 Review.
Cited by
-
Biomarkers and point of care screening approaches for the management of preeclampsia.Commun Med (Lond). 2024 Oct 22;4(1):208. doi: 10.1038/s43856-024-00642-4. Commun Med (Lond). 2024. PMID: 39433973 Free PMC article. Review.
-
Why Is Arginine the Only Amino Acid That Inhibits Polyglutamine Monomers from Taking on Toxic Conformations?ACS Chem Neurosci. 2024 Aug 7;15(15):2925-2935. doi: 10.1021/acschemneuro.4c00276. Epub 2024 Jul 15. ACS Chem Neurosci. 2024. PMID: 39009034 Free PMC article.
-
Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease.Acta Biomater. 2024 Jul 15;183:341-355. doi: 10.1016/j.actbio.2024.06.001. Epub 2024 Jun 5. Acta Biomater. 2024. PMID: 38849023
-
Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives.CNS Drugs. 2024 Jul;38(7):507-532. doi: 10.1007/s40263-024-01093-0. Epub 2024 Jun 3. CNS Drugs. 2024. PMID: 38829443 Free PMC article. Review.
-
Probing protein aggregation through spectroscopic insights and multimodal approaches: A comprehensive review for counteracting neurodegenerative disorders.Heliyon. 2024 Mar 18;10(7):e27949. doi: 10.1016/j.heliyon.2024.e27949. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38689955 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical